Quarterly report pursuant to Section 13 or 15(d)

NON CONTROLLING INTEREST (Details)

v3.20.1
NON CONTROLLING INTEREST (Details) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2020
Dec. 31, 2019
Net loss attributable to the non-controlling interest $ (11,626) $ (28)
BioCorRx Pharmaceuticals, Inc [Member]    
Net loss $ (48,039) $ (114)
Average Non-controlling interest percentage of profit/losses 24.20% 24.20%
Net loss attributable to the non-controlling interest $ (11,626) $ (28)